Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
-
WASHINGTON, DC, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Throughout the month of September, AmeriCorps CEO Michael D. Smith attended key events in Washington, DC, and New York, celebrating AmeriCorps'...
-
SAN JOSE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
-
Chicago, IL, Sept. 01, 2022 (GLOBE NEWSWIRE) -- September is Dental Implant Awareness Month, sponsored by the American Academy of Implant Dentistry (AAID). This month emphasizes the need to educate...
-
LEXINGTON, Mass. and AMSTERDAM, Sept. 07, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
-
ST. LOUIS, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Our skin takes a beating during the hotter months due to increased exposure to sunlight and humidity. Anyone spending more time outdoors, at the beach,...
-
VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced that its September 2020 distribution of $0.035 per unit has...
-
VANCOUVER, Colombie-Britannique, 16 sept. 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Émeraude ») (TSXV : EMH; OTCQX : EMHTF) a annoncé aujourd'hui sa participation à un panel et...
-
VANCOUVER, British Columbia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), today announced that it will participate in a panel and be...
-
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Aug. 30, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...